Trump Administration Seeks to Relax Rules on Cancer-Linked Sterilization Gas

Federal officials want to ease restrictions on ethylene oxide, a cancer-causing chemical used to clean medical equipment. The proposed changes would give companies more flexibility while potentially saving $43 million annually.

WASHINGTON – Federal environmental regulators are moving to relax restrictions on a cancer-causing chemical widely used to sterilize medical equipment, citing concerns that stricter rules could disrupt the supply of critical healthcare devices.

The Environmental Protection Agency announced Friday its intention to modify regulations governing ethylene oxide, a toxic gas essential for cleaning roughly half of all medical devices manufactured in the United States annually. The agency argues that tighter restrictions implemented during the Biden presidency in 2024 could interfere with manufacturers’ sterilization processes.

According to the EPA, the revised approach would maintain compliance with existing federal law while reducing regulatory burdens on companies that sterilize products ranging from heart stents to wound care supplies. The changes would also protect medical device supply chains and reduce industry costs.

Healthcare professionals, industry representatives, and Food and Drug Administration officials had raised objections to the more restrictive 2024 regulations. Those rules mandated additional risk assessments and required companies to install new monitoring equipment, ventilation systems, and containment structures.

Under the new proposal, medical device manufacturers would have options when dealing with facilities that emit more than 10 tons of ethylene oxide annually. Companies could choose between implementing new monitoring technology or making alternative modifications to ventilation systems in sterilization areas.

The EPA defended the changes in an official statement, saying: “These changes better reflect the complexity of facilities and give them the flexibility to work to use safe and effective equipment to sterilize medical tools and devices without compromising clean air for all Americans.”

The agency estimates the regulatory adjustments would generate approximately $43 million in annual savings across the industry.

Ethylene oxide, commonly abbreviated as EtO, appears as an invisible gas that effectively sterilizes equipment but releases harmful pollutants into the atmosphere. Medical research has established connections between prolonged exposure to the chemical and various cancers, particularly affecting individuals residing near manufacturing facilities that produce or utilize the substance.

The regulatory proposal will undergo public scrutiny through a hearing scheduled within approximately two weeks. Citizens and stakeholders will have 45 days to submit comments before federal officials finalize their decision.